Loading...
Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)
Garassino, M. C. Mazieres, J. Reck, M. Chouaid, C. Bischoff, H. Reinmuth, N. Cove-Smith, Laura Mansy, T. Cortinovis, D. Migliorino, M. R.
Garassino, M. C.
Mazieres, J.
Reck, M.
Chouaid, C.
Bischoff, H.
Reinmuth, N.
Cove-Smith, Laura
Mansy, T.
Cortinovis, D.
Migliorino, M. R.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Garassino MC, Mazieres J, Reck M, Chouaid C, Bischoff H, Reinmuth N, et al. 108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6). Vol. 33, Annals of Oncology. Elsevier BV; 2022. p. S81–2.